Skip to search formSkip to main contentSkip to account menu

Src/tubulin Inhibitor KX02

Known as: KX02, KX2-361 
A lipophilic, orally available inhibitor of both Src kinase activity and tubulin polymerization, with potential antineoplastic activity. Upon oral… 
National Institutes of Health

Related topics

Related topics

2 relations
Microtubule ProcessReceptor Tyrosine Kinase Inhibition

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
PurposeA major challenge to developing new therapies for patients with malignant brain tumors is that relatively few small… 
2010
2010
Abstract 5598: KX02, a novel therapeutic for glioma
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Objectives: Over 20,000 new cases of primary… 
2006
2006
NORMAL CONDUCTING HIGH-GRADIENT STUDIES AT KEK
Normal-conducting high-frequency high-field studies have been pursued at XTF, which is a high power X-band RF facility of KEK… 
2004
2004
PROGRESS TOWARD NLC/GLC PROTOTYPE ACCELERATOR STRUCTURES*
The accelerator structure groups for NLC (Next Linear Collider) and GLC (Global Linear Colliders) have successfully collaborated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)